These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical effect of indolidan in congestive heart failure. Corder CN, Puls A, Wilson M. Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):405-9. PubMed ID: 1446958 [Abstract] [Full Text] [Related]
23. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial. Behling A, Rohde LE, Colombo FC, Goldraich LA, Stein R, Clausell N. J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181 [Abstract] [Full Text] [Related]
25. Hemodynamic profile of the cardiotonic agent pimobendan. van Meel JC, Diederen W. J Cardiovasc Pharmacol; 1989 Apr; 14 Suppl 2():S1-6. PubMed ID: 2478784 [Abstract] [Full Text] [Related]
26. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S. Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669 [Abstract] [Full Text] [Related]
28. Long-term efficacy and safety of pimobendan in moderate heart failure. A double-blind parallel 6-month comparison with enalapril. The Pimobendan-Enalapril Study Group. Remme WJ, Krayenbühl HP, Baumann G, Frick MH, Haehl M, Nehmiz G, Baiker W. Eur Heart J; 1994 Jul; 15(7):947-56. PubMed ID: 7925517 [Abstract] [Full Text] [Related]
29. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study. G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585 [Abstract] [Full Text] [Related]
30. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group. Kubo SH, Gollub S, Bourge R, Rahko P, Cobb F, Jessup M, Brozena S, Brodsky M, Kirlin P, Shanes J. Circulation; 1992 Mar; 85(3):942-9. PubMed ID: 1537130 [Abstract] [Full Text] [Related]
31. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure. Schalcher C, Cotter G, Reisin L, Bertel O, Kobrin I, Guyene TT, Kiowski W. Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476 [Abstract] [Full Text] [Related]
33. [Effects of low dose pimobendan in patients with cor-pulmonale]. Nakatani M, Shirotani T, Kobayashi K, Satomi S, Ikeda Y, Kuniyoshi T, Tajiri E, Furuta Y, Motooka T. J Cardiol; 1999 Aug; 34(2):79-83. PubMed ID: 10466089 [Abstract] [Full Text] [Related]
34. [Effect of pimobendan on peripheral hemodynamics]. Peters P, Saborowski F, Kothe A. Z Kardiol; 1989 Aug; 78(8):538-44. PubMed ID: 2678794 [Abstract] [Full Text] [Related]
35. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial. Rolandi E, Sabino F, Cantoni V, Ghirardi P, Marchetti GV, Cicchetti V. J Cardiovasc Pharmacol; 1989 Aug; 14 Suppl 8():S93-103. PubMed ID: 2483446 [Abstract] [Full Text] [Related]